Mechanical Devices and US Food and Drug Administration (FDA) Approval

7Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Long-term ventricular assist devices for adults have advanced far more than have suitable devices for neonates and infants. The difficulties of design and construction of miniaturized blood pumping systems and the high costs associated with developing, testing, and approval of such devices has been prohibitive. Still, there is an important clinical need for such devices as the availability of donor hearts for this age group has been especially limited. Recently, several pneumatic pulsatile pumps have been developed based on the adult experience, and the issues of regulatory approval are now assuming greater importance for these devices. This chapter reviews the current system for medical device classification and the approval processes in the United States and in Europe. This system is continually evolving, with dedicated and knowledgeable professionals charged with assuring the efficacy, safety, appropriate labeling, and continuing surveillance of approved devices. Pediatric cardiac surgeons involved in transplantation and assist devices need to be aware of the regulatory issues, and work with manufacturers and governmental agencies to make sure that successful devices are available as soon as possible for their patients. © 2006 Elsevier Inc. All rights reserved.

Cite

CITATION STYLE

APA

Reitz, B. A. (2006). Mechanical Devices and US Food and Drug Administration (FDA) Approval. Pediatric Cardiac Surgery Annual, 9(1), 123–127. https://doi.org/10.1053/j.pcsu.2006.02.018

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free